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The usefulness of metabolic heat measurements in
quantifying the response of a solid tumour to anti-
cancer treatment was evaluated. The heat production
characteristic of malignant tissues, as measured from
human stomach, breast and liver cancer samples,
was observed to be inconsistent, and its value could
be higher or lower than that of its normal tissue of
origin. The various thermal activity responses of an
experimental rat hepatoma to hepatic artery ligation,
cryotherapy, intra-arterial (i.a) Adriamycin (2.4 mg/
kg), i.a. Norcantharidin (0.5 mg/kg) were next
studied. The tumour/liver (T/L) ratio of untreated
tumour-bearing rats was 0.83 but this fell to a
minimum at 24 h in both the hepatic artery ligation
and the cryosurgery groups. In these two groups
marked fluctuations in the heat production of
normal liver occurred with poor recovery of the T/
L ratio even at 2-- 3 weeks. In the Adriamycin group,
the T/L ratio dropped to a minimum at 5 days, and in
the Norcantharidin group, at 3 days. Minimal
disturbances in the thermal activity of liver tissue
occured in these two chemotherapy groups and the
T/L ratio recovered by 3 weeks. Norcantharidin
appeared as efficacious as Adriamycin in the
treatment of hepatoma when evaluated in terms of
thermal activity.
Keywords: Metabolic heat, Mylabris, Cantharidin, cryosur-
gery, ischaemia, microcalorimeter, hepatoma, Adriamycin
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INTRODUCTION
Although constant efforts are made to develop
better tests for cancer chemosensitivity [1-3],
there has been little progress in methods of
quantifying the efficacy of chemotherapy on
solid tumours. Traditional methods involve the
measurement of either the changes in the
tumour growth patterns or the prolongation of
host survival induced by the treatment [4]. There
are, in addition, a wide variety of techniques
which have been developed to allow the
quantification of the viability of malignant cells
in suspension prepared from animal tumours,
such as the end-point dilution assays [5] and
assays based on colony formation in vivo or in
vitro [6]. However, all these require the tedious
processes of removal of tumour cells from the
original animal, dispersal into single-cell sus-
pensions, enumeration of the cells, and finally, a
test of the growth potential of the cells, either in
new hosts or in cell culture. In addition, the
potential drawback of all these suspension
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procedures is the danger of selecting a sub-
population that might not be typical of the entire
tumour cell population.
A precise method for quantifying treatment
efficacy of liver cancer by measuring the glucose
oxidation of tumour tissue using a radio-tracer
technique was previously developed by the
author [7] and used for evaluating the efficacy
of Norcantharidin in the treatment of hepatoma
[8]. While that method was adequate in quanti-
fying short term tumour response, it could
become rather time-consuming and expensive
if repeated measurements were to be used for
monitoring tumour response on a long term
basis. With these considerations in mind, it was
decided to explore the use of thermal activity
measurements as an alternative method for
monitoring the long term response of an experi-
mental hepatoma to various forms of anti-cancer
treatment, including the drug Norcantharidin.
The present investigation is a sequel to the
authors’ previous study on the short term
efficacy of Norcantharidin in hepatoma [8]. The
objectives of the present study are four-fold: (1)
to study the feasibility of using microcalori-
metric measurements of tissue slices of different
organs, both normal and malignant, as overall
indices of their metabolic activities, (2) to study
the inter-strain and inter-gender variations in
thermal activity of rat liver tissue, (3) to
determine the tumour/liver ratio of the thermal
activity of an experimental hepatoma model in
the rat, and (4) to compare the long term efficacy
of intra-arterial Norcantharidin with three other
treatment modalities, namely intra-arterial
Adriamycin, hepatic artery ligation and cryo-
surgery in this experimental model using ther-
mal activity as an index of tumour response.
MATERIALS AND METHODS
Animals
One hundred and sixty-seven rats weighing
between 250-300 g (Laboratory Animal Centre,
National University of Singapore) were used in
this study. Of these, 17 were Wistar rats, another
10 were Sprague-Dawley rats, and the remaining
140 were of the inbred Buffalo strain. They were
kept in cages in an air-conditioned environment
at 25C under a twelve-hour cycle of alternating
darkness and illumination, fed a laboratory
pellet diet (Wayne Food, UK), and given tap
water ad libitum.
Animal Anaesthesia
Intramuscular Ketamine at a dose of 7.5 mg/kg
was as anaesthesia for all operative procedures
on the rat.
Cancer Cell Line
The cell line, Morris Hepatoma 7777, originally
induced in the Buffalo rat [9] was purchased
from American Type Cell Culture, Maryland,
USA, grown in Ham’s F12 nutrient medium
(Sigma Chemical Co, St Louis, MO, USA), and
used to produce the primary liver cancer model.
Anti-cancer Drugs
Adriamycin in 10 mg vials was purchased from
Farmitalia Carlo Erba Ltd, Herts, Italy. Nor-
cantharidin were purchased in glass ampoules
of 10 mg/2 ml from Beijing Fourth Pharmaceu-
tical Works, China.
Microcalorimeter
A commericial 2277 Thermal Activity Monitor
System (TAM) with four operating channels
(Thermometric AB, Jirfilla, Sweden), was used
to accurately measure the rate of heat produc-
tion of tissue specimens. Each channel consisted
of a twin thermopile heat conduction calori-
meter into which insertion vessels could be
introduced. The steel ampoule was loaded with
3 ml of the Hams F12 culture medium. The TAMHEPATOMA RESPONSE TO NORCANTHARIDIN 77
was coupled to a microcomputer and micro-
calorimetric data was collected with Digitam 3, a
software package specially designed for data
management and analysis with the TAM. As the
TAM had four channels, it was possible to
conduct concurrently, a maximum of 4 concur-
rent microcalorimetric measurements of a tissue
sample at any one time.
Sample Preparation
All tissue samples were immersed in F12
medium immediately upon harvesting. The
sample weights were kept small and in the
region of approximately 5 mg in order to avoid
the effect of metabolic crowding [10]. A scalpel
blade was used to slice the tissue sample into
smaller pieces of approximately 0.3 mm thick-
ness [11]. These tissue slices were next intro-
duced into the steel ampoule and the caps
tightened. The ampoule was then lowered into
the calorimeter, allowed to equilibrate with the
thermostated water bath and to generate a
power curve on the monitor.
Reproducibility of Measurements
punch biopsy specimens of a gastric adenocar-
cinoma and the adjacent normal stomach muco-
sa were obtained at endoscopy using a flexible
fibreoptic gastroscope (Olympus, Japan). From
the second and third patients who were both
suffering from infiltrative ductal breast carcino-
ma, samples of malignant and adjacent breast
tissues were harvested at maStectomy. Similarly,
liver and liver cancer specimens were harvested
at liver resection from the fourth and fifth
patients who had hepatocellular carcinoma.
Note was taken of the fact that the hepatocellular
carcinoma of the fifth patient was angiographi-
cally embolized with metal coils 3 weeks prior to
liver resection. All specimens were, upon har-
vesting, immediately immersed in Ham’s F12
medium and transported to the laboratory
within 5 minutes for thermal activity studies.
From the measurements, the peak thermal
power (Pmax) expressed as mJ/g wet weight,
was obtained for both normal and malignant
tissues. The degree of activity of the various
malignant tissues was then expressed as a
tumour/normal ratio, a ratio of the thermal
activity of tumour tissue to that of its corre-
sponding tissue of origin (Tab. II).
To gauge the reproducibility of thermal measure-
ments on tissue slices with the TAM, seven Wistar
rats were used. From each animal, a tissue sample
of either: (1) the small gut mucosa, (2) the heart, (3)
the brain, (4) the stomach, (5) the spleen, (6) the
gastrocnemius muscle or (7) the liver was
harvested. Concurrent quadruplicate measure-
ments were made on each of the seven tissue
samples. From the power curves generated, the
peak power in mJ/g wet wt was obtained and the
coefficient of variation was calculated for each
sample to evaluate the reproducibility of intra-
sample measurements (Tab. I).
Thermal Activity of Human Cancer Tissues
Fresh human cancer tissues were obtained from
five patients in this study. From the first patient,
Thermal Activity of Normal Organ Tissues
In 30 male Buffalo rats, tissue samples of
approximately 5 mg in size were harvested in
duplicate from the gastrocnemius muscle (n 4),
spleen (n 3), small gut (n 6), heart (n 3),
stomach (n 6), brain (n 3) and liver (n 5) and
their thermal activities were measured. In this
and all subsequent studies using animal tissues,
the results were expressed as the peak power in
mJ/g dry weight instead of per g wet weight
(Fig. 1). The dry weight could be calculated once
the wet wt./dry wt. ratio was obtained. Since
adequate animal tissues were available, it was
possible to obtain the wet wt./dry wt. ratio of the
various tissues by drying known weights of
tissue samples in a hot air oven at 45C for 3
weeks and re-weighing them after drying.78 P. MACK AND L.-Y. CHENG
TABLE Reproducibility of thermal activity measurements
Organ of interest Wt. of animal
(g)
Wet wt. of tissue Peak value of power Thermal activity
samples curve
(mg) (tJ) (mJ/g wet wt)
Reproducibility of
measurements
(C.V.%)
Small gut 300
Heart 289
Brain 275
Stomach 281
Spleen 286
Muscle 288
Liver 250
4.9 18.73 3.82 8.3
4.6 16.16 3.51
6.2 19.33 3.12
6.1 20.87 3.42
6.4 9.06 1.42 8.9
5.7 8.16 1.43
5.9 8.39 1.42
3.9 4.59 1.18
5.8 23.46 4.04 5.6
4.9 21.50 4.39
6.5 27.42 4.21
6.3 24.27 3.85
3.8 11.21 2.95 10.4
4.5 14.10 3.13
7.7 18.84 2.45
4.4 13.25 3.01
5.5 13.72 2.49 5.4
6.1 17.27 2.83
7.7 20.53 2.67
7.8 20.18 2.59
4.6 1.84 0.40 14.6
5.4 2.16 0.40
6.5 3.46 0.53
6.4 2.65 0.41
4.6 21.32 4.63 4.2
4.1 19.96 4.87
5.0 24.12 4.82
6.0 26.63 4.44
TABLE II Thermal activity of some Human cancers
Patient no. Organ of malignancy & Tissue sample Thermal activity mJ/g T/N ratio (Tumour/
histology wet wt. Normal)
Stomach Tumour
adenocarcinoma Normal stomach
2 Breast Tumour
infiltrative ductal carcinoma Normal breast
3 Breast Tumour
infiltrative ductal carcinoma Normal breast
4 Liver Tumour
hepatocellular carcinoma Normal liver
5 Liver Tumour (embolized)
hepatocellular carcinoma Normal liver
2.85 2.2
1.31
0.11 2.8
0.04
0.90 2.6
0.34
0.95 0.29
3.33
0.25 0.10
2.62
In this particular experiment, measurements of
the total amount of thermal power (mW/g dry
wt.) generated in the first hour by the various
tissue samples, as determined by the area under
the first hour of the power curve were also made.
This enabled the correlation of the values of the
peak power and the energy dissipated during the
first hour to be statistically studied.HEPATOMA RESPONSE TO NORCANTHARIDIN 79
Thermal Activities of Different Organs In Buffalo Rat
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FIGURE Thermal activity of various body organ tissues in the Buffalo rat expressed as the peak energy of the power curve in
mJ per gram dry weight of the tissue. Vertical bars represent standard deviations.
Thermal Activity of Normal Rat Liver Tissues
Thirty-two rats with equal numbers of male and
female animals were used to study the inter-
strain and inter-gender variations of the thermal
activity of the liver. Of the 32 animals, 10 were
Wistar, another 10 were Sprague-Dawley and
the remaining 12 were Buffalo rats. They were
anaesthetised, and liver biopsies of approxi-
mately 5 mg were harvested via a midline
laparotomy. Measurements of their peak power
were done in duplicates on the TAM and results
were expressed as mJ/g dry weight.
Primary Liver Cancer Model
The Morris Hepatoma 7777 cell line was used to
produce a solid tumour model. The cells were
cultured in Ham’s F12 nutrient medium in an
incubator at 37C at 95% oxygen and 5% carbon
dioxide for 4 days following which the cells
were harvested with 0.25% trypsin (Cytosytems
Co, Castle Hill Blue, Aust). Viability counts were
made after staining with trypan blue (Sigma
Chemical Co. USA). The tumour cells were then
resuspended in Ham’s F12 medium and 1.5 x 106
viable cells/0.1 ml were injected intraparenchy-
mally into the edge of the left lateral lobe of the
liver via a midline laparotomy. The abdomen
was closed with a 3 ’O’ Vicryl suture and the
animal allowed to recover from anaesthesia.
After two weeks, by which time the liver tumour
would have grown to a size of 1-2 cm3, the
inoculated animals were ready for experiments.
Liver Cancer Experiments
A total of 90 male hepatoma-bearing Buffalo rats
were used for this series of experiments. As a
baseline, 6 untreated male tumour-bearing Buf-
falo rats were sacrificed and samples of their
tumour and liver tissue of approximately 5 mg
in weight were harvested in duplicate for
thermal activity studies. The results obtained
from this group of animals were designated as
0 h, which is the baseline control for the four
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(a) Hepatic Artery Ligation Group
In a first group of 28 male tumour-bearing
Buffalo rats, a midline laparotomy was per-
formed and the falciform ligament and all
peritoneal attachments to the liver and the
hepatic branch of the hepato-oesophageal artery
were divided. The proper hepatic artery, the
continuation of the common hepatic artery after
giving off the gastroduodenal artery, was iden-
tified and ligated by a 6 ’O’ silk suture. The
laparotomy incisions were closed by a 3 ’O’
Vicryl suture and the animals were sacrificed at
1 h, 24 h, 3 days, 5 days, 7 days, 10 days, 14 days
and 21 days after interruption of hepatic arterial
blood flow. Upon sacrifice, tissue specimens of
approximately 5 mg each were harvested im-
mediately from the tumour and adjacent liver
parenchyma and were subjected to microcalori-
metric measurements in duplicate.
(b) Cryosurgery Group
In a second group of 19 male tumour-bearing
Buffalo rats, a midline laparotomy was per-
formed under anaesthesia and the liver turnout
was subjected to cryosurgical therapy. Cryo-
freezing was performed with the aid of Tissue-
Tek (Miles, Elkhart, USA), which is an embedding
medium for frozen tissue specimens containing
10.24% w/w polyvinyl alcohol, 4.26% w/w
polyethylene glycol and 85.5% w/w non-reac-
tive ingredients. The Tissue-Tek was immersed
in liquid nitrogen and frozen into a bolus of
approximately 1 cm in diameter. This frozen
bolus was applied directly over the surface of
the liver tumour for a few seconds and allowed
to soften slightly to fit the upper convex surface
of the turnout, thus freezing the turnout by
contact. The liver tumour was maintained in the
frozen state by repeated applications of liquid
nitrogen, dropwise from a 3 ml Pasteur pipette
onto the bolus Tissue-Tek. Care was taken to
ensure that the area of freezing was confined as
much as possible to the area of the tumour
tissue. After 20 minutes of freezing, the tumour
tissue was allowed to thaw. The laparotomy
incision was closed by 3 ’O’ Vicryl and the
animals were allowed to recover from anaes-
thesia in a warm environment under the Vicker
Medical Radiant Warmer (Model 183, UK). Post-
operatively, the rats were sacrificed at I h, 24 h, 3
days, 5 days, 7 days, 10 days, 14 days and 21
days. Both tumour and liver tissues were
harvested for microcalorimetric measurements.
(c) Intra-arterial Adriamycin Group
In the remaining two groups of the experiment,
all tumour-bearing rats underwent anaesthesia
and a midline laparotomy to expose the gastro-
duodenalbranch of the common hepatic artery.A
fine polyethylene cannula (Portex, 800/100/100/
100, UK) filled with normal saline, was inserted
under an operating microscope in a retrograde
direction into the gastroduodenal artery and
secured in position by a 6 ’O’ silk ligature.
In the third group of tumour-bearing rats
(n 21), a bolus dose of intra-arterial Adriamycin
at 2.4 mg/kg in 0.3 ml saline was infused over 5
minutes and the cannula was flushed with a
further infusion of 0.5 ml of normal saline.
(d) Intra-arterial Norcantharidin Group
In the fourth group of animals (n 16), a single
bolus dose of 0.5 mg/kg of intra-arterial Nor-
cantharidin was similarly given in each animal.
All laparotomy wounds were closed with 3 ’O’
Vicryl and all animals were sacrificed at 1 h, 24
h, 3 days, 5 days, 7 days, 10 days, 14 days and 21
days after intra-arterial drug administration.
Upon sacrifice, tissue specimens of approxi-
mately 5 mg each were harvested in duplicate
immediately from the turnout and adjacent liver
parenchyma for measurements in the microca-
lorimeter. The results of this and all the 3 other
groups in this series of experiment were ex-
pressed as mJ/g dry wt.HEPATOMA RESPONSE TO NORCANTHARIDIN 81
Statistics
All results were expressed as mean +/- standard
deviation. Analysis of variance (anova) and the
Student’s t-test were used for analysis of
differences between groups.
RESULTS
Reproducibility of Measurements
The coefficient of variation obtained through
quadruplicate measurements of a single sample
was 8.3 % for small gut, 8.9 % for heart, 5.6 % for
brain, 10.4 % for stomach, 5.4 % for spleen,
14.6 % for muscle and 4.2 % for liver.
Human Cancer Tissues Studies
The pattern of thermal activity of the human
cancers studied is shown in Table II. Of interest,
the stomach and breast cancer specimens pro-
duced more heat than their corresponding
tissues of origin, whereas the reverse was true
for primary liver cancer. When expressed as a
ratio of the heat production of tumour tissue
over that of the normal (T/N ratio), the tumour
activity was 2.2 in the patient with stomach
cancer, 2.8 and 2.6 respectively, in the two breast
cancer patients, 0.29 in one patient with liver
cancer and 0.10 in the other patient whose liver
cancer was embolized three weeks prior to liver
resection.
Normal Organ Tissue Studies
Thermal activity measurements showed that, the
peak power (Pmax) of the various tissues studied
were, in descending order, 11.91 +/-2.12 mJ/g dry
wt. for brain, 11.17 +/- 0.85 mJ/g dry wt. for liver,
8.05+/-2.30 mJ/g dry wt. for small gut,
6.08+/-1.25 mJ/g dry wt. for stomach,
5.84+/-0.74 mJ/g dry wt. for spleen, 3.03 +/- 1.10
mJ/g dry wt. for heart muscle, and 2.09 +/- 0.49
mJ/g dry wt. for skeletal muscle (Fig. 1). The
values of the Pmax were correlated with their
respective areas under the power curve for the
first hour, which represented the total energy
dissipated by the tissue specimen in the first
hour (Fig. 2). A highly significant correlation
was obtained (r 0.97, p < 0.001).
Correlation Between Peak Energy Value And
Total Power Over First Hour In Various Organs
0.96786
<0.001
12 14
Peak Thermal Energy mJig Dry Weight
FIGURE 2 Correlation between the area under the power curve (total thermal power in mW/g dry wt.) for the first hour with
the corresponding peak energy of the power curve Pmax in mJ/g dry wt. (r=0.97, p < 0.001).82 P. MACK AND L.-Y. CHENG
Normal Liver Studies
Thermal activity measurements of the rat liver
tissues showed no differences in heat production
amongst the males in the three strains, Wistar,
Sprague-Dawley and Buffalo (Tab. III). How-
ever, a significant difference did exist among the
female rats between the three strains (Anova,
p < 0.005). In all 3 rat strains, the liver tissue of
the males showed a significantly higher thermal
activity than that of the females, p < 0.00005 for
Buffalo, p < 0.00001 for Wistar and p < 0.05 for
Sprague-Dawley.
Liver Tumour Experiments
The baseline tumour/liver (T/L) ratio of un-
treated turnout-bearing rats was 0.83 (Tab. IV).
This T/L ratio dropped by one third to a level of
0.56 in the first hour after hepatic artery ligation.
The ratio fell to a minimum level of 0.12 (14% of
baseline) at 24 h. The thermal activity of the liver
fluctuated considerably during the first week of
TABLE III Thermal activity of normal liver tissue of
various rat strains
Rat strain Sex No. of Thermal activity P value
animals (n) mJ/g dry wt.
Buffalo Male 6 15.58 4- 0.45 < 0.00005
Female 6 13.27 4- 0.72
Wistar Male 5 15.46+ 0.43 < 0.00001
Female 5 12.34 4- 0.50
Sprague- Male 5 15.26+ 1.02 < 0.05
Dawley
Female 5 13.92+ 0.58
treatment but became more stable subsequently.
Recovery was slow and incomplete, only upto
0.52 at 3 weeks.
In the cryosurgery group, the T/L ratio
dropped by half to 0.40 and then to a minimum
of 0.14 (17 % of baseline) at 24 h. There was
marked fluctuation of the thermal activity of the
liver tissue in the cryosurgery group after
treatment (Fig. 3) and none of the treated
animals could survive up to 21 days to complete
the protocol. Of those that survived 14 days after
cryosurgery, the ratio came up to only 0.66.
In the Adriamycin group, the T/L ratio also
dropped by approximately half in the first hour
to 0.43. Further drop was prolonged and the
minimum of 0.22 (27% of baseline) was reached
at 5 days. Recovery in the Adriamycin-treated
group was however complete at 3 weeks.
In the Norcantharidin group the T/L ratio
dropped by a quarter to 0.63 in the first hour
after treatment. The ratio reached a minimum of
0.22 (27% of baseline) at 3 days. Recovery in the
Norcantharidin group was also complete by 3
weeks. In both the Adriamycin and Norcanthari-
din groups, the thermal activities of the liver
were noted to relatively stable throughout the
entire experiment (Fig. 4).
DISCUSSION
Microcalorimetry has the capacity of a general
analytical tool for the quantitative assessment of
TABLE IV Changes in T/L ratios following various anti-hepatoma treatments in rat model
Groups 0
hr
Tumour/Liver (T/L) ratios at various time points after treatment
24 3 5 7 10 14 21
hr hr days days days days days days
Hepatic artery 0.83
ligation (n 6)
Cryosurgery 0.83
(20 min) (n 6)
I/A Adriamycin 0.83
(2.4 mg/kg) (n 6)
I/A Norcantharidin 0.83
(0.5 mg/kg) (n 6)
0.56 0.12 0.25 0.26 0.20 0.27 0.55 0.52
(n 4) (n 4) (n 3) (n 3) (n 4) (n 3) (n 3) (n 4)
0.40 0.15 0.19 0.08 0.57 0.55 0.66
(n 4) (n 3) (n 2) (n 3) (n 3) (n 2) (n 2)
0.43 0.24 0.23 0.21 0.29 0.70 0.75 0.80
(n 2) (n 2) (n 2) (n 4) (n 2) (n 3) (n 3) (n 3)
0.63 0.28 0.22 0.26 0.34 0.71 0.94 0.81
(n 2) (n 2) (n 2) (n 2) (n 2) (n 2) (n 2) (n 2)HEPATOMA RESPONSE TO NORCANTHARIDIN 83
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mg/kg (in the top half of the graph) and with i.a.
Norcantharidin at 0.5 mg/kg (in the bottom half of the
graph). The fluctuations in liver tissue activity were minimal
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that of Figure 3.
the overall physical and chemical changes of
many living cellular systems [12] including the
study of the process of microbial metabolism,
the evaluation of erythrocytes in hyperthyroid
states, and even for the study of isolated
hepatocytes [13]. Modern microcalorimetry has
the advantages of good sensitivity and easy
automation, making it an excellent method for
observation of the overall metabolic activity of
cell processes. Knowledge of the difference in
heat production between normal and neoplastic
cells led to the application of the microcalori-
metric method in the monitoring of the response
of leukaemia and lymphoma patients to treat-
ment, [14-16] and subsequently in the predic-
tion of sensitivity of neoplastic cells to
chemotherapy [17, 18].
An extension of the use of microcalorimetry
from pure cellular systems to living tissue slices
enabled the technique to be used for monitoring
small changes in tissue metabolism occurring in
in-vivo systems. Asakawa and his colleagues
[19, 20] successfully applied the tissue-slice
technique to small liver biopsy specimens and
was able to repeatedly quantify the heat produc-
tion of liver tissues biopsied from living rats
undergoing hepatic ischaemia and re-perfusion
studies. In this study, the authors extended this
application successfully for the monitoring of
heat production changes in experimental liver
cancer undergoing various forms of anti-cancer
treatment. The results in this study indicated
potential usefulness of metabolic heat measure-
ments as a bioassay of tumour activity. As a84 P. MACK AND L.-Y. CHENG
result, the authors were able to adequately
assess the long term efficacy of Norcantharidin,
a relatively unknown anti-cancer drug, in
comparison with conventional modalities of
anti-hepatoma treatment.
An initial pilot study of the various major
solid organ tissues of the body showed that the
liver had by comparison, one of the highest level
of thermal activity (Fig. 1) with good reprodu-
cibility of measurements (Tab. I). This rendered
the microcalorimetric method appropriate for
evaluating changes in the thermal activities of
liver and liver tumours with anti-cancer treat-
ment. The high correlation between the peak
activity and area under the power curve over the
first hour enabled the authors to conveniently
adopt the peak value as a quick and reliable
indicator for monitoring cancer tissue activity.
Of note, the microcalorimetric method has been
found sufficiently sensitive to detect subtle inter-
gender as well as inter-strain differences in rat
liver tissue activity.
Although it is common knowledge that the
metabolism of most malignant tissues were
higher than their normal tissues of origin
because of exaggerated glycolysis [21], metabolic
heat measurements in this study did not
consistently show exaggerated heat production
of malignant tissues over their normal counter-
parts as expected. Of the human cancer speci-
mens examined, heat production from both the
gastric and breast carcinoma tissues were found
to be more than twice that of their normal
counterparts, whereas .hepatocellular carcinoma
tissue was only 0.3 that of normal liver tissue.
The tumour/liver ratio in the patient with an
embolized liver tumour was noted to be three
times as low as the patient without emboliza-
tion. This last observation however, was con-
sistent with the authors’ surmise that metabolic
heat measurement could be useful as a bioassay
for tumour activity, before and after treatment.
In the authors’ previous study, it was shown
that the glucose oxidation rate of the rat Morris
Hepatoma model (or T/L ratio) was 4.2 times that
of normal liver tissue [8]. Yet, in the present study
where thermal activity was used as an index of
tumour activity, the T/L ratio was only 0.83. This
apparent paradox can be explained by the fact
that heat production measured in such situations
did not represent merely the heat generated from
glycolysis alone, but the sum activity of the total
physico-chemical processes of the biological
system that resulted in heat dissipated to the
surrounding medium. Of interest, Monti [15]
similarly noted that the heat production in
peripheral blood lymphocytes of chronic lym-
phocytic leukaemia patients was also lower than
that of lymphocytes of healthy subjects.
In the palliative treatment of non-resectable
primary liver cancers, a variety of therapeutic
modalities are currently available. Surgical liga-
tion of the hepatic artery is a traditional method
of proven value, but is a once-off treatment with
only short-term efficacy because the liver tu-
mour will regain its arterial supply through
collaterals some weeks later [22]. Cryosurgical
therapy of liver cancers is a relatively new
modality, and has shown encouraging results.
However, since it is conducted intra-operatively
it is also an once-off treatment, but it is possible
to combine its use with intra-arterial chemother-
apy. In the present study, both these two
physical methods of treatment were shown to
be more potent as compared with the two forms
of intra-arterial chemotherapy. Their maximum
effects were seen in 24 hours compared to 3 days
in Norcantharidin and 5 days in Adriamycin. In
addition, their recovery were also delayed as
compared to the two intra-arterial chemother-
apy groups in which recovery was complete
within 3 weeks. The constitutional disturbance
caused by the cryotherapy as reflected by the
significant fluctuations in the values of heat
production of the post-treated liver, probably
accounted for the mortality of the animals noted
in this group.
Adriamycin is a well and long established
chemotherapeutic agent for primary hepatocel-
lular carcinoma, but the use of NorcantharidinHEPATOMA RESPONSE TO NORCANTHARIDIN 85
in this disease is much less well known.
Norcantharidin is the demethylated form of
Cantharidin, which is the active ingredient of
the blister beetle, Mylabris, a long used Chinese
traditional medicine. Cantharidin had been
shown in China to have an effect on primary
hepatoma, but the use was limited by its severe
toxicity for the mucuous membranes of the gas-
trointestinal and urinary tract [8]. The analogue
Norcantharidin was subsequently developed
and it is known to possess significant anti-
hepatoma activity but at the same time relatively
free from side-effects, including bone marrow
suppression [23]. In an earlier study by the
author [8], it was shown that, when given by the
intra-arterial route, Norcantharidin suppressed
oxidative glucose metabolism by nearly 50%
within one hour of administration. The present
study showed that the heat production dropped
by only 75% within the first hour but it exerted
its maximum effect within 3 days of adminis-
tration and recovery was complete by 3 weeks.
In conclusion, thermal activity measurement
by microcalorimetry is a precise and convenient
method of monitoring the long term response of
an experimental hepatoma to treatment. The
efficacy of physical modes of therapy in the form
of arterial ischaemia and cryotherapy appeared
more intense and to have a faster onset, when
compared to the chemotherapeutic forms of
treatment usingAdriamycin and Norcantharidin.
Norcantharidin, when given intra-arterially in
this study, appeared to be at least as efficacious as
Adriamycin. The information obtained herein
also provided some clues on the pharmacody-
namics of intra-arterial Norcantharidin on a
hepatoma model, and .the knowledge thus
acquired might help to improve scheduling of
chemotherapy regimens in the future.
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COMMENTARY MANUSCRIPT
THE THERMAL ACTIVITY OF NORMAL
AND MALIGNANT TISSUES-
MICROCALORIMETRIC RESPONSE
OF LIVER CANCER TO HEPATIC ARTERY
LIGATION, CRYOSURGERY, ADRIAMYCIN
AND NORCANTHARIDIN
This is an experimental study on the usefulness
of metabolic heat measurements in quantifying
tumour response to anti-cancer treatment. The
increased heat production has been measured
mostly in malignancies of hematopoetic and
lymphatic systems and shows a good correlation
to long term prognosis and response to therapy.
However, its use in similar evaluation in solid
tumours have not been studied much since there
are some methodologic errors. Its use in the
study of malignant tumours of the GI tract is
hampered by the presence of bacteria which
may have a significant influence on the heat
production in the small tissue sections that are
used. Its use in organs outside the GI mucosa,
e.g., liver as well as breast tissue is interesting. In
this paper the authors have shown some
correlation with reduction of heat production
in liver tumours after treatment with hepatic
artery ligation or cryosurgery. Similar findings
were observed after treatment with adriamycin
or norcantharidin. There is, however, a fairly
wide variation and this may indicate that the
technique needs further refinement. The authors
have also included some human data showing
that this is a technique that is applicable in the
clinic. Here the authors show that tumours of
the stomach and breast have a higher thermal
activity than normal tissue but in the liver with
hepatocellular carcinoma the opposite is found.
This is in contrast to the experimental study but
one of the tumours was treated with emboliza-
tion and thus data for only one clinical observa-
tion remain. Therefore the interpretation must
be performed with caution. May be the hepato-
cellular carcinoma is unique among the tumours
studied it mostly is highly differentiated and the
difference to normal tissue may not be so
pronounced.
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